LHKOREA12

<p><a href="https://www.sedaily.com/NewsView/2DD5KHYBB2" target="_top" class="ke-link">FDA 정조준…'제2 렉라자' 도전은 계속된다 | 서울경제 (sedaily.com)</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="FDA 정조준…'제2 렉라자' 도전은 계속된다" data-og-description="문화·스포츠 > 헬스 뉴스: 유한양행(000100)이 개발한 비소세폐암 치료제 ‘렉라자’의 미국 식품의약국(FDA) 허가로 블록버스터(연 매출 1조 원 의약품)급..." data-og-host="www.sedaily.com" data-og-source-url="https://www.sedaily.com/NewsView/2DD5KHYBB2" data-og-url="https://www.sedaily.com/NewsView/2DD5KHYBB2/GH1403" data-og-image="https://scrap.kakaocdn.net/dn/dV7yaK/hyWVZXbmt8/ZQHQ9h5cK8521ZkpLAOqz1/img.jpg?width=640&height=334&face=0_0_640_334,https://scrap.kakaocdn.net/dn/kQXcy/hyWV5XqoyN/8okwHUJRsEsh1nDSUFJp0k/img.jpg?width=640&height=334&face=0_0_640_334,https://scrap.kakaocdn.net/dn/c3AxBg/hyWVSqfeTH/jCzn5kM8Au8GHIDhR7a7gk/img.jpg?width=640&height=334&face=0_0_640_334"><a href="https://www.sedaily.com/NewsView/2DD5KHYBB2" target="_blank" data-source-url="https://www.sedaily.com/NewsView/2DD5KHYBB2"><div class="og-image"><img src="https://scrap.kakaocdn.net/dn/dV7yaK/hyWVZXbmt8/ZQHQ9h5cK8521ZkpLAOqz1/img.jpg?width=640&height=334&face=0_0_640_334,https://scrap.kakaocdn.net/dn/kQXcy/hyWV5XqoyN/8okwHUJRsEsh1nDSUFJp0k/img.jpg?width=640&height=334&face=0_0_640_334,https://scrap.kakaocdn.net/dn/c3AxBg/hyWVSqfeTH/jCzn5kM8Au8GHIDhR7a7gk/img.jpg?width=640&height=334&face=0_0_640_334" alt="" xxonerror="this.src="//img1.kakaocdn.net/thumb/C200x200/?fname=https%3A%2F%2Ft1.daumcdn.net%2Fcafe_image%2Fcafe_meta_image_190529.png""></div><div class="og-text"><p class="og-title">FDA 정조준…'제2 렉라자' 도전은 계속된다</p><p class="og-desc">문화·스포츠 > 헬스 뉴스: 유한양행(000100)이 개발한 비소세폐암 치료제 ‘렉라자’의 미국 식품의약국(FDA) 허가로 블록버스터(연 매출 1조 원 의약품)급...</p><p class="og-host">www.sedaily.com</p></div></a></div><p> </p>